Eva Netterlid

1.1k total citations
19 papers, 764 citations indexed

About

Eva Netterlid is a scholar working on Epidemiology, Dermatology and Microbiology. According to data from OpenAlex, Eva Netterlid has authored 19 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 6 papers in Dermatology and 6 papers in Microbiology. Recurrent topics in Eva Netterlid's work include Contact Dermatitis and Allergies (6 papers), Bacterial Infections and Vaccines (5 papers) and Pneumonia and Respiratory Infections (4 papers). Eva Netterlid is often cited by papers focused on Contact Dermatitis and Allergies (6 papers), Bacterial Infections and Vaccines (5 papers) and Pneumonia and Respiratory Infections (4 papers). Eva Netterlid collaborates with scholars based in Sweden, United Kingdom and Spain. Eva Netterlid's co-authors include Pär Sparén, Alexander Ploner, Joakim Dillner, Lisen Arnheim‐Dahlström, Eva Herweijer, Rigmor Thorstensson, Maja Jahnmatz, Julia F. Simard, Amy Levál and Sandra Eloranta and has published in prestigious journals such as JAMA, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Eva Netterlid

19 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Netterlid Sweden 13 416 171 135 126 113 19 764
B. Ultsch Germany 18 527 1.3× 138 0.8× 82 0.6× 88 0.7× 88 0.8× 48 782
Ian F. Cook Australia 14 249 0.6× 96 0.6× 36 0.3× 136 1.1× 223 2.0× 29 808
Angela Guo United States 11 717 1.7× 163 1.0× 19 0.1× 166 1.3× 33 0.3× 27 974
Lawrence D. Frenkel United States 18 506 1.2× 97 0.6× 65 0.5× 241 1.9× 41 0.4× 54 993
Julie Rowe Australia 17 351 0.8× 33 0.2× 151 1.1× 100 0.8× 56 0.5× 21 1.1k
Siew‐Kim Khoo Australia 19 261 0.6× 35 0.2× 23 0.2× 96 0.8× 52 0.5× 46 761
Barbara Pahud United States 14 292 0.7× 133 0.8× 36 0.3× 264 2.1× 82 0.7× 36 616
P. M. Matricardi Italy 15 214 0.5× 24 0.1× 52 0.4× 75 0.6× 56 0.5× 22 711
Robert B. Wainwright United States 19 871 2.1× 182 1.1× 93 0.7× 187 1.5× 149 1.3× 26 1.4k
Paul Hunter United States 12 358 0.9× 192 1.1× 56 0.4× 135 1.1× 32 0.3× 16 553

Countries citing papers authored by Eva Netterlid

Since Specialization
Citations

This map shows the geographic impact of Eva Netterlid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Netterlid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Netterlid more than expected).

Fields of papers citing papers by Eva Netterlid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Netterlid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Netterlid. The network helps show where Eva Netterlid may publish in the future.

Co-authorship network of co-authors of Eva Netterlid

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Netterlid. A scholar is included among the top collaborators of Eva Netterlid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Netterlid. Eva Netterlid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bruze, M., et al.. (2020). Patch testing with aluminum chloride hexahydrate in petrolatum. Contact Dermatitis. 83(2). 176–177. 4 indexed citations
2.
Nilsson, Lennart, Knut Brockow, Johan Alm, et al.. (2017). Vaccination and allergy: EAACI position paper, practical aspects. Pediatric Allergy and Immunology. 28(7). 628–640. 87 indexed citations
3.
Hindsén, Monica, et al.. (2016). Contact allergy in atopic individuals in relation to allergen-specific immunotherapy. European Journal of Dermatology. 26(3). 271–280. 4 indexed citations
4.
Rehn, Moa, Ingrid Uhnoo, Sharon Kühlmann‐Berenzon, et al.. (2016). Highest Vaccine Uptake after School-Based Delivery - A County-Level Evaluation of the Implementation Strategies for HPV Catch-Up Vaccination in Sweden. PLoS ONE. 11(3). e0149857–e0149857. 27 indexed citations
5.
Herweijer, Eva, Adina L. Feldman, Alexander Ploner, et al.. (2015). The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study. PLoS ONE. 10(7). e0134185–e0134185. 35 indexed citations
7.
Jahnmatz, Maja, Margaretha Ljungman, Eva Netterlid, et al.. (2014). Pertussis-Specific Memory B-Cell and Humoral IgG Responses in Adolescents after a Fifth Consecutive Dose of Acellular Pertussis Vaccine. Clinical and Vaccine Immunology. 21(9). 1301–1308. 12 indexed citations
8.
Netterlid, Eva, et al.. (2014). Young Individuals With Atopic Disease and Asthma or Rhinoconjunctivitis May Have Clinically Relevant Contact Allergies. Dermatitis. 25(3). 115–119. 10 indexed citations
9.
Herweijer, Eva, Amy Levál, Alexander Ploner, et al.. (2014). Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma. JAMA. 311(6). 597–597. 73 indexed citations
10.
Netterlid, Eva, et al.. (2013). Does Allergen-specific Immunotherapy Induce Contact Allergy to Aluminium?. Acta Dermato Venereologica. 93(1). 50–56. 27 indexed citations
11.
Jahnmatz, Maja, et al.. (2013). Optimization of a human IgG B-cell ELISpot assay for the analysis of vaccine-induced B-cell responses. Journal of Immunological Methods. 391(1-2). 50–59. 107 indexed citations
12.
Levál, Amy, Eva Herweijer, Alexander Ploner, et al.. (2013). Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study. JNCI Journal of the National Cancer Institute. 105(7). 469–474. 113 indexed citations
13.
Gidudu, Jane, Gary A. Walco, Anna Taddio, et al.. (2012). Immunization site pain: Case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 30(30). 4558–4577. 26 indexed citations
14.
15.
Stefanoff, Paweł, Svenn‐Erik Mamelund, Mary Robinson, et al.. (2010). Tracking parental attitudes on vaccination across European countries: The Vaccine Safety, Attitudes, Training and Communication Project (VACSATC). Vaccine. 28(35). 5731–5737. 109 indexed citations
16.
Hallander, Hans O., Mikael Andersson, Lennart Gustafsson, Margaretha Ljungman, & Eva Netterlid. (2009). Seroprevalence of pertussis antitoxin (anti‐PT) in Sweden before and 10 years after the introduction of a universal childhood pertussis vaccination program. Apmis. 117(12). 912–922. 45 indexed citations
17.
Netterlid, Eva, Marie Edwinson Månsson, & Anders Håkansson. (2009). Surveillance of Vaccine Safety: Comparison of parental reports with routine surveillance and a clinical trial. Vaccine. 27(14). 2042–2047. 12 indexed citations
19.
Netterlid, Eva, M. Bruze, Monica Hindsén, Marléne Isaksson, & P Olin. (2004). Persistent itching nodules after the fourth dose of diphtheria–tetanus toxoid vaccines without evidence of delayed hypersensitivity to aluminium. Vaccine. 22(27-28). 3698–3706. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026